MTOR and isolated focal cortical dysplasia type II: ,39–41 Increased mTORC1 activity has been shown in FCD type II and HME specimens from patients with somatic mutations in mTOR pathway activating genes (MTOR, PIK3CA, AKT3 and RHEB).9